Skip to main content

Table 1 ABVD protocol administered to twin pregnant women

From: Maternal ABVD chemotherapy for Hodgkin lymphoma in a dichorionic diamniotic pregnancy: a case report

Patient: 41 years old

Weight (kg): 85

Size (cm): 173

Body surface area (m2): 1,99

Creatinine (μmol/L): 58

Clearance(mL/min, Cockroft Gault): 151

Unit: Hematology

Cycle 1 J1 = November 08, 2017

Cycle duration: 28 days

 

Drug

Dose of protocol

Total dose

Vehicle

Medical device

Route

Duration

Timing

Doxorubicin

25 mg/m2

50 mg

Glucose 5% 20 mL

Syringe

Intravenous

5 min

J1 and J15

Bleomycin

10 mg/m2

19.8 mg

Sodium chloride 0.9% 20 mL

Syringe

Intravenous

5 min

J1 and J15

Vinblastine

5 mg/m2

10 mg

Sodium chloride 0.9% 20 mL

Bag

Intravenous

5 min

J1 and J15

Dacarbazine

375 mg/m2

750 mg

Glucose 5% 250 mL

Bag

Infusion

45 min

J1 and J15

Ondansetron

8 mg

8 mg

No dilution

 

Intravenous

1 min

J1 and J15

Dexamethasone

10 mg

10 mg

No dilution

 

Intravenous

5 min

J1 and J15

  1. Monitoring: hemogram, C-reactive protein (CRP), creatininemia, liver checkup